Complications and survival following percutaneous endoscopic gastrostomy tube placement.

IF 2.7 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Diego Casas Deza, Rosario María Monzón Baez, Luis Javier Lamuela Calvo, Elena Betoré Glaria, Enrique Montil Miguel, Belén Julián Gomara, Raquel Vicente Lidón
{"title":"Complications and survival following percutaneous endoscopic gastrostomy tube placement.","authors":"Diego Casas Deza, Rosario María Monzón Baez, Luis Javier Lamuela Calvo, Elena Betoré Glaria, Enrique Montil Miguel, Belén Julián Gomara, Raquel Vicente Lidón","doi":"10.17235/reed.2024.10335/2024","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>percutaneous endoscopic gastrostomy (PEG) is considered as a safe and effective method for nutritional support in patients with malnutrition and swallowing impairment with an estimated survival of over two months. Some indications, such as advanced cognitive decline, contraindicate the technique.</p><p><strong>Materials and methods: </strong>all patients who underwent PEG placement between January 2001 and May 2019 were included. Clinical data, indication, complications, and mortality were retrospectively analyzed.</p><p><strong>Results: </strong>a total of 648 patients (46.5 % male, mean age 70 ± 18.5 years) were included. The most common indications for PEG were advanced cognitive decline (31.5 %) and cerebrovascular disease (18.8 %). The mean follow-up was 12.07 months (IQR 3.27-34.73); 39.5 % of patients experienced complications (systemic 17.9 %, local 28.5 %). The most frequent were bronchoaspiration (9.7 %) and rupture/dysfunction (13.9 %), respectively. The presence of early complications (HR 1.63 [1.20-2.21]) and age (HR 1.02 [1.01-1.02]) was associated with shorter survival time, while female sex was a protective factor (HR 0.78 [0.66-0.94]).</p><p><strong>Conclusions: </strong>PEG is not without complications, with 39.5 % of patients experiencing them. Patients with early complications, male sex and older age have lower survival following PEG placement.</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola De Enfermedades Digestivas","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17235/reed.2024.10335/2024","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: percutaneous endoscopic gastrostomy (PEG) is considered as a safe and effective method for nutritional support in patients with malnutrition and swallowing impairment with an estimated survival of over two months. Some indications, such as advanced cognitive decline, contraindicate the technique.

Materials and methods: all patients who underwent PEG placement between January 2001 and May 2019 were included. Clinical data, indication, complications, and mortality were retrospectively analyzed.

Results: a total of 648 patients (46.5 % male, mean age 70 ± 18.5 years) were included. The most common indications for PEG were advanced cognitive decline (31.5 %) and cerebrovascular disease (18.8 %). The mean follow-up was 12.07 months (IQR 3.27-34.73); 39.5 % of patients experienced complications (systemic 17.9 %, local 28.5 %). The most frequent were bronchoaspiration (9.7 %) and rupture/dysfunction (13.9 %), respectively. The presence of early complications (HR 1.63 [1.20-2.21]) and age (HR 1.02 [1.01-1.02]) was associated with shorter survival time, while female sex was a protective factor (HR 0.78 [0.66-0.94]).

Conclusions: PEG is not without complications, with 39.5 % of patients experiencing them. Patients with early complications, male sex and older age have lower survival following PEG placement.

经皮内镜胃造瘘管置入术后的并发症和存活率。
导言:经皮内镜胃造口术(PEG)被认为是一种安全有效的营养支持方法,适用于营养不良和吞咽障碍患者,估计存活期超过两个月。某些适应症,如晚期认知功能衰退,则禁用该技术:纳入 2001 年 1 月至 2019 年 5 月期间接受 PEG 置入术的所有患者。对临床数据、适应症、并发症和死亡率进行了回顾性分析:共纳入 648 例患者(46.5% 为男性,平均年龄(70±18.5)岁)。最常见的 PEG 适应症是晚期认知功能衰退(31.5%)和脑血管疾病(18.8%)。平均随访时间为 12.07 个月(IQR 3.27-34.73)。39.5%的患者出现并发症(全身17.9%,局部28.5%)。最常见的并发症分别是支气管吸入(9.7%)和破裂/功能障碍(13.9%)。早期并发症(HR 1.63 [1.20-2.21])和年龄(HR 1.02 [1.01-1.02])与存活时间缩短有关,而女性是一个保护因素(HR 0.78 [0.66-0.94]):结论:PEG并非没有并发症,39.5%的患者会出现并发症。结论:PEG 并非没有并发症,39.5% 的患者会出现并发症。患有晚期痴呆症、男性、年龄较大和全身并发症的患者在置入 PEG 后存活率较低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.00
自引率
25.00%
发文量
400
审稿时长
6-12 weeks
期刊介绍: La Revista Española de Enfermedades Digestivas, Órgano Oficial de la Sociedad Española de Patología Digestiva (SEPD), Sociedad Española de Endoscopia Digestiva (SEED) y Asociación Española de Ecografía Digestiva (AEED), publica artículos originales, editoriales, revisiones, casos clínicos, cartas al director, imágenes en patología digestiva, y otros artículos especiales sobre todos los aspectos relativos a las enfermedades digestivas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信